[1]
A. Wesmii Ibrahim and I. H. . Mohsin, “Seroprevalence of Epstein-Barr Virus Antibodies and Complement C3/C4 Levels in Immunocompromised (Malignant Tumors and Organ Transplant Recipients) Patients”, IJApSc, vol. 2, no. 3, pp. 24–34, Sep. 2025, doi: 10.69923/hqk7rr18.